John W. Bristol & Co Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IFX
INFINEON TECH AG ADS(REP1 ORD)
IFX
|
+$56.1M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$41.4M |
| 3 |
Intuitive Surgical
ISRG
|
+$22.1M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$2.29M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$33.6M |
| 2 |
Progressive
PGR
|
+$31.4M |
| 3 |
Chipotle Mexican Grill
CMG
|
+$21.2M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.31M |
| 5 |
Microsoft
MSFT
|
+$1.08M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.39% |
| 2 | Consumer Discretionary | 16.05% |
| 3 | Communication Services | 15.91% |
| 4 | Healthcare | 14.45% |
| 5 | Financials | 12.59% |
Similar funds
John W. Bristol & Co's Q3 2022 Portfolio in Review
As of Q3 2022, John W. Bristol & Co held 81 positions worth $4B, down 2% from $4.08B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
John W. Bristol & Co deployed $156M of net new capital in Q3 2022, opening 4 new positions and adding to 33 existing holdings. Its largest new stake was INFINEON TECH AG ADS(REP1 ORD): 2,555,668 shares worth $56.1M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was UnitedHealth, an estimated $33.6M trimmed.
- John W. Bristol & Co's largest Q3 2022 buy was INFINEON TECH AG ADS(REP1 ORD): 2,555,668 shares worth $56.1M.
- John W. Bristol & Co added most to Intuitive Surgical in Q3 2022, an estimated $22.1M increase.
- John W. Bristol & Co's biggest Q3 2022 reduction was UnitedHealth, cutting an estimated $33.6M.
- John W. Bristol & Co's ten largest holdings make up 34% of its $4B portfolio in Q3 2022.
- John W. Bristol & Co opened 4 new positions and closed 0 in Q3 2022.
- John W. Bristol & Co's portfolio value fell 2% quarter-over-quarter to $4B.
Based on John W. Bristol & Co's 13F filing for Q3 2022, filed 1 Nov 2022.